Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lorenzo Gerratana

Showing results (21-30 of 127) with videos related to

Pageof 13
Sort By:
Journal of Experimental & Clinical Cancer Research : CR|July 17, 2019
APE1 and NPM1 protect cancer cells from platinum compounds cytotoxicity and their expression pattern has a prognostic value in TNBCMatilde Clarissa Malfatti, Lorenzo Gerratana, Emiliano Dalla, et al.
Annals of Translational Medicine|February 22, 2019
Third-generation tyrosine kinase inhibitor in the treatment of epidermal growth factor receptor mutated squamous cell lung cancer: a tailored therapy approachFrancesco Cortiula, Giovanna De Maglio, Maria Giulia Cangi, et al.
Frontiers in Oncology|August 3, 2023
Editorial: Altered expression of proteins in cancer: function and potential therapeutic targets, volume IIJoão Pessoa, Maria Teresa Valenti, Nadège Bellance, et al.
Oncotargets and Therapy|September 14, 2016
Real-time tests of multiple genome alterations take the first steps into the clinic: a learning exampleLorenzo Gerratana, Giovanna De Maglio, Alessandro De Pellegrin, et al.
Future Oncology (London, England)|September 13, 2016
Caring for cancer survivors: perspectives of oncologists, general practitioners and patients in ItalyFabio Puglisi, Elisa Agostinetto, Lorenzo Gerratana, et al.
Frontiers in Oncology|February 28, 2022
Image Analysis of Circulating Tumor Cells and Leukocytes Predicts Survival and Metastatic Pattern in Breast Cancer PatientsGiacomo Da Col, Fabio Del Ben, Michela Bulfoni, et al.
Expert Opinion on Drug Safety|October 1, 2013
Factors affecting patient's perception of anticancer treatments side-effects: an observational studyStefania Russo, Marika Cinausero, Lorenzo Gerratana, et al.
Molecular Diagnosis & Therapy|August 30, 2025
Evolutionary Overview and Future Perspectives: ESR1 Mutations, Liquid Biopsy, and Artificial Intelligence for a New Era of Personalized Medicine in ER+ Breast CancerSerafina Martella, Giacomo Cusumano, Thilini Hemali Senevirathne, et al.
International Journal of Cancer|September 28, 2018
BET proteins regulate homologous recombination-mediated DNA repair: BRCAness and implications for cancer therapyCatia Mio, Lorenzo Gerratana, Marco Bolis, et al.
Melanoma Research|February 1, 2019
Prognostic role of disease extent and lymphocyte-monocyte ratio in advanced melanomaDonatella Iacono, Debora Basile, Lorenzo Gerratana, et al.
Pageof 13

Showing results (21-30 of 127) with videos related to

Sort By:
Pageof 13
Journal of Experimental & Clinical Cancer Research : CR|July 17, 2019
APE1 and NPM1 protect cancer cells from platinum compounds cytotoxicity and their expression pattern has a prognostic value in TNBCMatilde Clarissa Malfatti, Lorenzo Gerratana, Emiliano Dalla, et al.
Annals of Translational Medicine|February 22, 2019
Third-generation tyrosine kinase inhibitor in the treatment of epidermal growth factor receptor mutated squamous cell lung cancer: a tailored therapy approachFrancesco Cortiula, Giovanna De Maglio, Maria Giulia Cangi, et al.
Frontiers in Oncology|August 3, 2023
Editorial: Altered expression of proteins in cancer: function and potential therapeutic targets, volume IIJoão Pessoa, Maria Teresa Valenti, Nadège Bellance, et al.
Oncotargets and Therapy|September 14, 2016
Real-time tests of multiple genome alterations take the first steps into the clinic: a learning exampleLorenzo Gerratana, Giovanna De Maglio, Alessandro De Pellegrin, et al.
Future Oncology (London, England)|September 13, 2016
Caring for cancer survivors: perspectives of oncologists, general practitioners and patients in ItalyFabio Puglisi, Elisa Agostinetto, Lorenzo Gerratana, et al.
Frontiers in Oncology|February 28, 2022
Image Analysis of Circulating Tumor Cells and Leukocytes Predicts Survival and Metastatic Pattern in Breast Cancer PatientsGiacomo Da Col, Fabio Del Ben, Michela Bulfoni, et al.
Expert Opinion on Drug Safety|October 1, 2013
Factors affecting patient's perception of anticancer treatments side-effects: an observational studyStefania Russo, Marika Cinausero, Lorenzo Gerratana, et al.
Molecular Diagnosis & Therapy|August 30, 2025
Evolutionary Overview and Future Perspectives: ESR1 Mutations, Liquid Biopsy, and Artificial Intelligence for a New Era of Personalized Medicine in ER+ Breast CancerSerafina Martella, Giacomo Cusumano, Thilini Hemali Senevirathne, et al.
International Journal of Cancer|September 28, 2018
BET proteins regulate homologous recombination-mediated DNA repair: BRCAness and implications for cancer therapyCatia Mio, Lorenzo Gerratana, Marco Bolis, et al.
Melanoma Research|February 1, 2019
Prognostic role of disease extent and lymphocyte-monocyte ratio in advanced melanomaDonatella Iacono, Debora Basile, Lorenzo Gerratana, et al.
Pageof 13